What Is Going on With Nabriva Therapeutics (NBRV) Stock Today?
Source: iQoncept | Shutterstock Nabriva Therapeutics (NASDAQ: NBRV ) stock caught the attention of traders on Friday after shares surged in price this morning. However, not all is as it seems. While shares of NBRV stock rocketed more than 2,000% , that was only due to the company’s stock undergoing a reverse stock split. This saw it consolidate 25 shares of NBRV stock into a single share of stock. Whne this happens, it doesn’t affect the total stake an investor holds in NBRV. Instead, it just sees the total number of outstanding shares reduced. In this case, it drops outstanding shares from 69.7 million to approximately 2.8 million. NBRV Stock Avoids Delisting Companies choose to enact reverse stock splits for several reasons. That includes boosting the price of their stock to meet minimum listing requirements. This is the case for NBRV stock as it previously was below the $1 minimum needed to remain on the Nasdaq Exchange . With the reverse stock split, the biopharmaceutical avoided delisting by boosting its share price from around 18 cents to the mid $4 range.
What Is Going on With Nabriva Therapeutics (NBRV) Stock Today?
Source: iQoncept | Shutterstock Nabriva Therapeutics (NASDAQ: NBRV ) stock caught the attention of traders on Friday after shares surged in price this morning. However, not all is as it seems. While shares of NBRV stock rocketed more than 2,000% , that was only due to the company’s stock undergoing a reverse stock split. This saw it consolidate 25 shares of NBRV stock into a single share of stock. Whne this happens, it doesn’t affect the total stake an investor holds in NBRV. Instead, it just sees the total number of outstanding shares reduced. In this case, it drops outstanding shares from 69.7 million to approximately 2.8 million. NBRV Stock Avoids Delisting Companies choose to enact reverse stock splits for several reasons. That includes boosting the price of their stock to meet minimum listing requirements. This is the case for NBRV stock as it previously was below the $1 minimum needed to remain on the Nasdaq Exchange . With the reverse stock split, the biopharmaceutical avoided delisting by boosting its share price from around 18 cents to the mid $4 range.